| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | CAY10594 | CTRPv2 | pan-cancer | AAC | -0.054 | 0.2 |
| mRNA | DMOG | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | selumetinib:UNC0638 (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.079 | 0.2 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.075 | 0.2 |
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.043 | 0.2 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.05 | 0.2 |
| mRNA | compound 1B | CTRPv2 | pan-cancer | AAC | -0.052 | 0.2 |
| mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.048 | 0.2 |